Ticker
BIOACompany Name
BIOAGE LABS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 322.15M | $ 220.33M | 68.39% |
3/31/2025 | $ 343.84M | $ 257.49M | 74.89% |
12/31/2024 | $ 358.23M | $ 354.35M | 98.92% |
9/30/2024 | $ 337.38M | $ 334.47M | 99.14% |
6/30/2024 | $ 164.4M | $ 159.09M | 96.77% |
12/31/2023 | $ 25.92M | $ 24.96M | 96.27% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for BIOAGE LABS INC is calculated as follows: CashnEq [ $ 24.96M ] / Assets [ $ 25.92M ]
(=) Cash to Assets [ 96.27% ]
Minimum
Jun 30, 2025
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.8% |
average | 9.79% |
median | 6.44% |
std | 9.55% |